News

FDA opens probe into mysterious death linked to gene therapy
The Food & Drug Administration is investigating the death of an 8‑year‑old following Elevidys gene therapy for Duchenne ...
Yahoo Finance1mon
Sarepta and Roche halt DMD gene therapy’s use after second death
Two fatal ALF cases have occurred in the gene therapy’s use to date. Shares in Swiss-listed Roche fell 1% at market open following the development, while Sarepta was down 31.34% in pre-market ...
Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best low priced pharma stocks to buy now. Towards the end of June, ...
Reuters1y
Sarepta surges as investors cheer expanded use of gene therapy
Sarepta Therapeutics shares surged as much as 40% to a more than three-year high on Friday as an expanded use approval cemented its dominant position in the gene therapy market for Duchenne ...
Two boys died after a gene therapy. This family won’t give up hope.
The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...